Aecom Reports Q4 Results, Joins Incyte And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Benzinga10minutes ago

Incyte's $750 Million Escient Deal Faces Setback With Toxicology Issues In Two Investigational Drugs, Analyst Flags Challenges

Benzinga13minutes ago

Tuesday Market Falls, SMCI Flies, Big Box Retail Reports Mixed | Live Stock

Kevin Travers11:11 ET

JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas

Seeking Alpha11:06 ET

Cantor Fitzgerald Reiterates Neutral on Incyte

BenzingaNov 19 09:21 ET

Incyte Analyst Ratings

BenzingaNov 19 09:20 ET · Ratings